You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Medication use evaluation: Ceftazidime-Avibactam combination therapy compared to Ceftazidime-Avibactam monotherapy
- At: Seville (Spain) (2022)
- Type: Digital
- By: CHEN, Pei-chun (Taipei City Hospital Yangming Branch, China Taiwan)
- Co-author(s): Ms Pei-chun Chen (Taipei City Hospital Yangming Branch, Taipei, China Taiwan)
Mr. Kai-Hsiang Yang, Pharmacy (Taipei City Hospital Yangming Branch, Taipei, China Taiwan) - Abstract:
Background information: The medicinal product Ceftazidime-Avibactam (Zavicefta®) is first-line therapy for the treatment of refractory infections caused by Gram-negative bacilli.
Purpose: The purpose of this study was to evaluate the efficacy and adverse effects of Ceftazidime-Avibactam combined with other antibiotics and Ceftazidime-Avibactam.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026